img

Global Bi-Specific MAbS Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Bi-Specific MAbS Market Insights, Forecast to 2034

Bispecific monoclonal antibodies are used to improve immune response in various medical conditions and finds its applications in the field of drug delivery and cancer immunotherapy.
Market Analysis and InsightsGlobal Bi-Specific MAbS Market
The global Bi-Specific MAbS market is projected to grow from US$ million in 2024 to US$ million by 2034, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Bi-Specific MAbS is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Bi-Specific MAbS is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Bi-Specific MAbS is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The global key companies of Bi-Specific MAbS include Johnson and Johnson, Novartis AG, Hoffmann-La Roche Ltd., Chugai Pharmaceutical, Bayer AG, Thermo Fisher Scientific, Bistro-Myers Squibb, Mylan N.V. and Daiichi Sankyo Company, etc. in 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Bi-Specific MAbS market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2024, and projections of CAGR through 2034.
This report researches the key producers of Bi-Specific MAbS, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Bi-Specific MAbS, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Bi-Specific MAbS revenue, market share and industry ranking of main companies, data from 2018 to 2024. Identification of the major stakeholders in the global Bi-Specific MAbS market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2034. Evaluation and forecast the market size for Bi-Specific MAbS revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Johnson and Johnson, Novartis AG, Hoffmann-La Roche Ltd., Chugai Pharmaceutical, Bayer AG, Thermo Fisher Scientific, Bistro-Myers Squibb, Mylan N.V. and Daiichi Sankyo Company, etc.



By Company


Johnson and Johnson
Novartis AG
Hoffmann-La Roche Ltd.
Chugai Pharmaceutical
Bayer AG
Thermo Fisher Scientific
Bistro-Myers Squibb
Mylan N.V.
Daiichi Sankyo Company
Abbott
AstraZeneca
Eli Lilly
Merck and Co.
Amgen
Pfizer
GlaxoSmithKline plc
Roche
Segment by Type
Catumaxomab
Blinatumomab
Duligotumab
SAR 156597

Segment by Application


Cancer
Autoimmune Diseases
Inflammatory Diseases
Infectious Diseases
Microbial Diseases
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Revenue of Bi-Specific MAbS in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3Detailed analysis of Bi-Specific MAbS companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by type, by application and by country, revenue for each segment.
Chapter 7Europe by type, by application and by country, revenue for each segment.
Chapter 8China by type and by application revenue for each segment.
Chapter 9Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Bi-Specific MAbS revenue, gross margin, and recent development, etc.
Chapter 12Analyst's Viewpoints/Conclusions

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bi-Specific MAbS Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Catumaxomab
1.2.3 Blinatumomab
1.2.4 Duligotumab
1.2.5 SAR 156597
1.3 Market by Application
1.3.1 Global Bi-Specific MAbS Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Cancer
1.3.3 Autoimmune Diseases
1.3.4 Inflammatory Diseases
1.3.5 Infectious Diseases
1.3.6 Microbial Diseases
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bi-Specific MAbS Market Perspective (2018-2034)
2.2 Global Bi-Specific MAbS Growth Trends by Region
2.2.1 Bi-Specific MAbS Market Size by Region: 2018 VS 2022 VS 2034
2.2.2 Bi-Specific MAbS Historic Market Size by Region (2018-2024)
2.2.3 Bi-Specific MAbS Forecasted Market Size by Region (2024-2034)
2.3 Bi-Specific MAbS Market Dynamics
2.3.1 Bi-Specific MAbS Industry Trends
2.3.2 Bi-Specific MAbS Market Drivers
2.3.3 Bi-Specific MAbS Market Challenges
2.3.4 Bi-Specific MAbS Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Bi-Specific MAbS by Players
3.1.1 Global Bi-Specific MAbS Revenue by Players (2018-2024)
3.1.2 Global Bi-Specific MAbS Revenue Market Share by Players (2018-2024)
3.2 Global Bi-Specific MAbS Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Bi-Specific MAbS, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Bi-Specific MAbS Market Concentration Ratio
3.4.1 Global Bi-Specific MAbS Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bi-Specific MAbS Revenue in 2022
3.5 Global Key Players of Bi-Specific MAbS Head office and Area Served
3.6 Global Key Players of Bi-Specific MAbS, Product and Application
3.7 Global Key Players of Bi-Specific MAbS, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Bi-Specific MAbS Breakdown Data by Type
4.1 Global Bi-Specific MAbS Historic Market Size by Type (2018-2024)
4.2 Global Bi-Specific MAbS Forecasted Market Size by Type (2024-2034)
5 Bi-Specific MAbS Breakdown Data by Application
5.1 Global Bi-Specific MAbS Historic Market Size by Application (2018-2024)
5.2 Global Bi-Specific MAbS Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Bi-Specific MAbS Market Size (2018-2034)
6.2 North America Bi-Specific MAbS Market Size by Type
6.2.1 North America Bi-Specific MAbS Market Size by Type (2018-2024)
6.2.2 North America Bi-Specific MAbS Market Size by Type (2024-2034)
6.2.3 North America Bi-Specific MAbS Market Share by Type (2018-2034)
6.3 North America Bi-Specific MAbS Market Size by Application
6.3.1 North America Bi-Specific MAbS Market Size by Application (2018-2024)
6.3.2 North America Bi-Specific MAbS Market Size by Application (2024-2034)
6.3.3 North America Bi-Specific MAbS Market Share by Application (2018-2034)
6.4 North America Bi-Specific MAbS Market Size by Country
6.4.1 North America Bi-Specific MAbS Market Size by Country: 2018 VS 2022 VS 2034
6.4.2 North America Bi-Specific MAbS Market Size by Country (2018-2024)
6.4.3 North America Bi-Specific MAbS Market Size by Country (2024-2034)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Bi-Specific MAbS Market Size (2018-2034)
7.2 Europe Bi-Specific MAbS Market Size by Type
7.2.1 Europe Bi-Specific MAbS Market Size by Type (2018-2024)
7.2.2 Europe Bi-Specific MAbS Market Size by Type (2024-2034)
7.2.3 Europe Bi-Specific MAbS Market Share by Type (2018-2034)
7.3 Europe Bi-Specific MAbS Market Size by Application
7.3.1 Europe Bi-Specific MAbS Market Size by Application (2018-2024)
7.3.2 Europe Bi-Specific MAbS Market Size by Application (2024-2034)
7.3.3 Europe Bi-Specific MAbS Market Share by Application (2018-2034)
7.4 Europe Bi-Specific MAbS Market Size by Country
7.4.1 Europe Bi-Specific MAbS Market Size by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Bi-Specific MAbS Market Size by Country (2018-2024)
7.4.3 Europe Bi-Specific MAbS Market Size by Country (2024-2034)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Bi-Specific MAbS Market Size (2018-2034)
8.2 China Bi-Specific MAbS Market Size by Type
8.2.1 China Bi-Specific MAbS Market Size by Type (2018-2024)
8.2.2 China Bi-Specific MAbS Market Size by Type (2024-2034)
8.2.3 China Bi-Specific MAbS Market Share by Type (2018-2034)
8.3 China Bi-Specific MAbS Market Size by Application
8.3.1 China Bi-Specific MAbS Market Size by Application (2018-2024)
8.3.2 China Bi-Specific MAbS Market Size by Application (2024-2034)
8.3.3 China Bi-Specific MAbS Market Share by Application (2018-2034)
9 Asia (excluding China)
9.1 Asia Bi-Specific MAbS Market Size (2018-2034)
9.2 Asia Bi-Specific MAbS Market Size by Type
9.2.1 Asia Bi-Specific MAbS Market Size by Type (2018-2024)
9.2.2 Asia Bi-Specific MAbS Market Size by Type (2024-2034)
9.2.3 Asia Bi-Specific MAbS Market Share by Type (2018-2034)
9.3 Asia Bi-Specific MAbS Market Size by Application
9.3.1 Asia Bi-Specific MAbS Market Size by Application (2018-2024)
9.3.2 Asia Bi-Specific MAbS Market Size by Application (2024-2034)
9.3.3 Asia Bi-Specific MAbS Market Share by Application (2018-2034)
9.4 Asia Bi-Specific MAbS Market Size by Region
9.4.1 Asia Bi-Specific MAbS Market Size by Region: 2018 VS 2022 VS 2034
9.4.2 Asia Bi-Specific MAbS Market Size by Region (2018-2024)
9.4.3 Asia Bi-Specific MAbS Market Size by Region (2024-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Bi-Specific MAbS Market Size (2018-2034)
10.2 Middle East, Africa, and Latin America Bi-Specific MAbS Market Size by Type
10.2.1 Middle East, Africa, and Latin America Bi-Specific MAbS Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Bi-Specific MAbS Market Size by Type (2024-2034)
10.2.3 Middle East, Africa, and Latin America Bi-Specific MAbS Market Share by Type (2018-2034)
10.3 Middle East, Africa, and Latin America Bi-Specific MAbS Market Size by Application
10.3.1 Middle East, Africa, and Latin America Bi-Specific MAbS Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Bi-Specific MAbS Market Size by Application (2024-2034)
10.3.3 Middle East, Africa, and Latin America Bi-Specific MAbS Market Share by Application (2018-2034)
10.4 Middle East, Africa, and Latin America Bi-Specific MAbS Market Size by Country
10.4.1 Middle East, Africa, and Latin America Bi-Specific MAbS Market Size by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa, and Latin America Bi-Specific MAbS Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Bi-Specific MAbS Market Size by Country (2024-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Johnson and Johnson
11.1.1 Johnson and Johnson Company Details
11.1.2 Johnson and Johnson Business Overview
11.1.3 Johnson and Johnson Bi-Specific MAbS Introduction
11.1.4 Johnson and Johnson Revenue in Bi-Specific MAbS Business (2018-2024)
11.1.5 Johnson and Johnson Recent Developments
11.2 Novartis AG
11.2.1 Novartis AG Company Details
11.2.2 Novartis AG Business Overview
11.2.3 Novartis AG Bi-Specific MAbS Introduction
11.2.4 Novartis AG Revenue in Bi-Specific MAbS Business (2018-2024)
11.2.5 Novartis AG Recent Developments
11.3 Hoffmann-La Roche Ltd.
11.3.1 Hoffmann-La Roche Ltd. Company Details
11.3.2 Hoffmann-La Roche Ltd. Business Overview
11.3.3 Hoffmann-La Roche Ltd. Bi-Specific MAbS Introduction
11.3.4 Hoffmann-La Roche Ltd. Revenue in Bi-Specific MAbS Business (2018-2024)
11.3.5 Hoffmann-La Roche Ltd. Recent Developments
11.4 Chugai Pharmaceutical
11.4.1 Chugai Pharmaceutical Company Details
11.4.2 Chugai Pharmaceutical Business Overview
11.4.3 Chugai Pharmaceutical Bi-Specific MAbS Introduction
11.4.4 Chugai Pharmaceutical Revenue in Bi-Specific MAbS Business (2018-2024)
11.4.5 Chugai Pharmaceutical Recent Developments
11.5 Bayer AG
11.5.1 Bayer AG Company Details
11.5.2 Bayer AG Business Overview
11.5.3 Bayer AG Bi-Specific MAbS Introduction
11.5.4 Bayer AG Revenue in Bi-Specific MAbS Business (2018-2024)
11.5.5 Bayer AG Recent Developments
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Details
11.6.2 Thermo Fisher Scientific Business Overview
11.6.3 Thermo Fisher Scientific Bi-Specific MAbS Introduction
11.6.4 Thermo Fisher Scientific Revenue in Bi-Specific MAbS Business (2018-2024)
11.6.5 Thermo Fisher Scientific Recent Developments
11.7 Bistro-Myers Squibb
11.7.1 Bistro-Myers Squibb Company Details
11.7.2 Bistro-Myers Squibb Business Overview
11.7.3 Bistro-Myers Squibb Bi-Specific MAbS Introduction
11.7.4 Bistro-Myers Squibb Revenue in Bi-Specific MAbS Business (2018-2024)
11.7.5 Bistro-Myers Squibb Recent Developments
11.8 Mylan N.V.
11.8.1 Mylan N.V. Company Details
11.8.2 Mylan N.V. Business Overview
11.8.3 Mylan N.V. Bi-Specific MAbS Introduction
11.8.4 Mylan N.V. Revenue in Bi-Specific MAbS Business (2018-2024)
11.8.5 Mylan N.V. Recent Developments
11.9 Daiichi Sankyo Company
11.9.1 Daiichi Sankyo Company Company Details
11.9.2 Daiichi Sankyo Company Business Overview
11.9.3 Daiichi Sankyo Company Bi-Specific MAbS Introduction
11.9.4 Daiichi Sankyo Company Revenue in Bi-Specific MAbS Business (2018-2024)
11.9.5 Daiichi Sankyo Company Recent Developments
11.10 Abbott
11.10.1 Abbott Company Details
11.10.2 Abbott Business Overview
11.10.3 Abbott Bi-Specific MAbS Introduction
11.10.4 Abbott Revenue in Bi-Specific MAbS Business (2018-2024)
11.10.5 Abbott Recent Developments
11.11 AstraZeneca
11.11.1 AstraZeneca Company Details
11.11.2 AstraZeneca Business Overview
11.11.3 AstraZeneca Bi-Specific MAbS Introduction
11.11.4 AstraZeneca Revenue in Bi-Specific MAbS Business (2018-2024)
11.11.5 AstraZeneca Recent Developments
11.12 Eli Lilly
11.12.1 Eli Lilly Company Details
11.12.2 Eli Lilly Business Overview
11.12.3 Eli Lilly Bi-Specific MAbS Introduction
11.12.4 Eli Lilly Revenue in Bi-Specific MAbS Business (2018-2024)
11.12.5 Eli Lilly Recent Developments
11.13 Merck and Co.
11.13.1 Merck and Co. Company Details
11.13.2 Merck and Co. Business Overview
11.13.3 Merck and Co. Bi-Specific MAbS Introduction
11.13.4 Merck and Co. Revenue in Bi-Specific MAbS Business (2018-2024)
11.13.5 Merck and Co. Recent Developments
11.14 Amgen
11.14.1 Amgen Company Details
11.14.2 Amgen Business Overview
11.14.3 Amgen Bi-Specific MAbS Introduction
11.14.4 Amgen Revenue in Bi-Specific MAbS Business (2018-2024)
11.14.5 Amgen Recent Developments
11.15 Pfizer
11.15.1 Pfizer Company Details
11.15.2 Pfizer Business Overview
11.15.3 Pfizer Bi-Specific MAbS Introduction
11.15.4 Pfizer Revenue in Bi-Specific MAbS Business (2018-2024)
11.15.5 Pfizer Recent Developments
11.16 GlaxoSmithKline plc
11.16.1 GlaxoSmithKline plc Company Details
11.16.2 GlaxoSmithKline plc Business Overview
11.16.3 GlaxoSmithKline plc Bi-Specific MAbS Introduction
11.16.4 GlaxoSmithKline plc Revenue in Bi-Specific MAbS Business (2018-2024)
11.16.5 GlaxoSmithKline plc Recent Developments
11.17 Roche
11.17.1 Roche Company Details
11.17.2 Roche Business Overview
11.17.3 Roche Bi-Specific MAbS Introduction
11.17.4 Roche Revenue in Bi-Specific MAbS Business (2018-2024)
11.17.5 Roche Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Bi-Specific MAbS Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2034
Table 2. Key Players of Catumaxomab
Table 3. Key Players of Blinatumomab
Table 4. Key Players of Duligotumab
Table 5. Key Players of SAR 156597
Table 6. Global Bi-Specific MAbS Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2034
Table 7. Global Bi-Specific MAbS Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 8. Global Bi-Specific MAbS Market Size by Region (2018-2024) & (US$ Million)
Table 9. Global Bi-Specific MAbS Market Share by Region (2018-2024)
Table 10. Global Bi-Specific MAbS Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 11. Global Bi-Specific MAbS Market Share by Region (2024-2034)
Table 12. Bi-Specific MAbS Market Trends
Table 13. Bi-Specific MAbS Market Drivers
Table 14. Bi-Specific MAbS Market Challenges
Table 15. Bi-Specific MAbS Market Restraints
Table 16. Global Bi-Specific MAbS Revenue by Players (2018-2024) & (US$ Million)
Table 17. Global Bi-Specific MAbS Revenue Share by Players (2018-2024)
Table 18. Global Top Bi-Specific MAbS by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bi-Specific MAbS as of 2022)
Table 19. Global Bi-Specific MAbS Industry Ranking 2021 VS 2022 VS 2024
Table 20. Global 5 Largest Players Market Share by Bi-Specific MAbS Revenue (CR5 and HHI) & (2018-2024)
Table 21. Global Key Players of Bi-Specific MAbS, Headquarters and Area Served
Table 22. Global Key Players of Bi-Specific MAbS, Product and Application
Table 23. Global Key Players of Bi-Specific MAbS, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Bi-Specific MAbS Market Size by Type (2018-2024) & (US$ Million)
Table 26. Global Bi-Specific MAbS Revenue Market Share by Type (2018-2024)
Table 27. Global Bi-Specific MAbS Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 28. Global Bi-Specific MAbS Revenue Market Share by Type (2024-2034)
Table 29. Global Bi-Specific MAbS Market Size by Application (2018-2024) & (US$ Million)
Table 30. Global Bi-Specific MAbS Revenue Share by Application (2018-2024)
Table 31. Global Bi-Specific MAbS Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 32. Global Bi-Specific MAbS Revenue Share by Application (2024-2034)
Table 33. North America Bi-Specific MAbS Market Size by Type (2018-2024) & (US$ Million)
Table 34. North America Bi-Specific MAbS Market Size by Type (2024-2034) & (US$ Million)
Table 35. North America Bi-Specific MAbS Market Size by Application (2018-2024) & (US$ Million)
Table 36. North America Bi-Specific MAbS Market Size by Application (2024-2034) & (US$ Million)
Table 37. North America Bi-Specific MAbS Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 38. North America Bi-Specific MAbS Market Size by Country (2018-2024) & (US$ Million)
Table 39. North America Bi-Specific MAbS Market Size by Country (2024-2034) & (US$ Million)
Table 40. Europe Bi-Specific MAbS Market Size by Type (2018-2024) & (US$ Million)
Table 41. Europe Bi-Specific MAbS Market Size by Type (2024-2034) & (US$ Million)
Table 42. Europe Bi-Specific MAbS Market Size by Application (2018-2024) & (US$ Million)
Table 43. Europe Bi-Specific MAbS Market Size by Application (2024-2034) & (US$ Million)
Table 44. Europe Bi-Specific MAbS Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 45. Europe Bi-Specific MAbS Market Size by Country (2018-2024) & (US$ Million)
Table 46. Europe Bi-Specific MAbS Market Size by Country (2024-2034) & (US$ Million)
Table 47. China Bi-Specific MAbS Market Size by Type (2018-2024) & (US$ Million)
Table 48. China Bi-Specific MAbS Market Size by Type (2024-2034) & (US$ Million)
Table 49. China Bi-Specific MAbS Market Size by Application (2018-2024) & (US$ Million)
Table 50. China Bi-Specific MAbS Market Size by Application (2024-2034) & (US$ Million)
Table 51. Asia Bi-Specific MAbS Market Size by Type (2018-2024) & (US$ Million)
Table 52. Asia Bi-Specific MAbS Market Size by Type (2024-2034) & (US$ Million)
Table 53. Asia Bi-Specific MAbS Market Size by Application (2018-2024) & (US$ Million)
Table 54. Asia Bi-Specific MAbS Market Size by Application (2024-2034) & (US$ Million)
Table 55. Asia Bi-Specific MAbS Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 56. Asia Bi-Specific MAbS Market Size by Region (2018-2024) & (US$ Million)
Table 57. Asia Bi-Specific MAbS Market Size by Region (2024-2034) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Bi-Specific MAbS Market Size by Type (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Bi-Specific MAbS Market Size by Type (2024-2034) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Bi-Specific MAbS Market Size by Application (2018-2024) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Bi-Specific MAbS Market Size by Application (2024-2034) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Bi-Specific MAbS Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 63. Middle East, Africa, and Latin America Bi-Specific MAbS Market Size by Country (2018-2024) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Bi-Specific MAbS Market Size by Country (2024-2034) & (US$ Million)
Table 65. Johnson and Johnson Company Details
Table 66. Johnson and Johnson Business Overview
Table 67. Johnson and Johnson Bi-Specific MAbS Product
Table 68. Johnson and Johnson Revenue in Bi-Specific MAbS Business (2018-2024) & (US$ Million)
Table 69. Johnson and Johnson Recent Developments
Table 70. Novartis AG Company Details
Table 71. Novartis AG Business Overview
Table 72. Novartis AG Bi-Specific MAbS Product
Table 73. Novartis AG Revenue in Bi-Specific MAbS Business (2018-2024) & (US$ Million)
Table 74. Novartis AG Recent Developments
Table 75. Hoffmann-La Roche Ltd. Company Details
Table 76. Hoffmann-La Roche Ltd. Business Overview
Table 77. Hoffmann-La Roche Ltd. Bi-Specific MAbS Product
Table 78. Hoffmann-La Roche Ltd. Revenue in Bi-Specific MAbS Business (2018-2024) & (US$ Million)
Table 79. Hoffmann-La Roche Ltd. Recent Developments
Table 80. Chugai Pharmaceutical Company Details
Table 81. Chugai Pharmaceutical Business Overview
Table 82. Chugai Pharmaceutical Bi-Specific MAbS Product
Table 83. Chugai Pharmaceutical Revenue in Bi-Specific MAbS Business (2018-2024) & (US$ Million)
Table 84. Chugai Pharmaceutical Recent Developments
Table 85. Bayer AG Company Details
Table 86. Bayer AG Business Overview
Table 87. Bayer AG Bi-Specific MAbS Product
Table 88. Bayer AG Revenue in Bi-Specific MAbS Business (2018-2024) & (US$ Million)
Table 89. Bayer AG Recent Developments
Table 90. Thermo Fisher Scientific Company Details
Table 91. Thermo Fisher Scientific Business Overview
Table 92. Thermo Fisher Scientific Bi-Specific MAbS Product
Table 93. Thermo Fisher Scientific Revenue in Bi-Specific MAbS Business (2018-2024) & (US$ Million)
Table 94. Thermo Fisher Scientific Recent Developments
Table 95. Bistro-Myers Squibb Company Details
Table 96. Bistro-Myers Squibb Business Overview
Table 97. Bistro-Myers Squibb Bi-Specific MAbS Product
Table 98. Bistro-Myers Squibb Revenue in Bi-Specific MAbS Business (2018-2024) & (US$ Million)
Table 99. Bistro-Myers Squibb Recent Developments
Table 100. Mylan N.V. Company Details
Table 101. Mylan N.V. Business Overview
Table 102. Mylan N.V. Bi-Specific MAbS Product
Table 103. Mylan N.V. Revenue in Bi-Specific MAbS Business (2018-2024) & (US$ Million)
Table 104. Mylan N.V. Recent Developments
Table 105. Daiichi Sankyo Company Company Details
Table 106. Daiichi Sankyo Company Business Overview
Table 107. Daiichi Sankyo Company Bi-Specific MAbS Product
Table 108. Daiichi Sankyo Company Revenue in Bi-Specific MAbS Business (2018-2024) & (US$ Million)
Table 109. Daiichi Sankyo Company Recent Developments
Table 110. Abbott Company Details
Table 111. Abbott Business Overview
Table 112. Abbott Bi-Specific MAbS Product
Table 113. Abbott Revenue in Bi-Specific MAbS Business (2018-2024) & (US$ Million)
Table 114. Abbott Recent Developments
Table 115. AstraZeneca Company Details
Table 116. AstraZeneca Business Overview
Table 117. AstraZeneca Bi-Specific MAbS Product
Table 118. AstraZeneca Revenue in Bi-Specific MAbS Business (2018-2024) & (US$ Million)
Table 119. AstraZeneca Recent Developments
Table 120. Eli Lilly Company Details
Table 121. Eli Lilly Business Overview
Table 122. Eli Lilly Bi-Specific MAbS Product
Table 123. Eli Lilly Revenue in Bi-Specific MAbS Business (2018-2024) & (US$ Million)
Table 124. Eli Lilly Recent Developments
Table 125. Merck and Co. Company Details
Table 126. Merck and Co. Business Overview
Table 127. Merck and Co. Bi-Specific MAbS Product
Table 128. Merck and Co. Revenue in Bi-Specific MAbS Business (2018-2024) & (US$ Million)
Table 129. Merck and Co. Recent Developments
Table 130. Amgen Company Details
Table 131. Amgen Business Overview
Table 132. Amgen Bi-Specific MAbS Product
Table 133. Amgen Revenue in Bi-Specific MAbS Business (2018-2024) & (US$ Million)
Table 134. Amgen Recent Developments
Table 135. Pfizer Company Details
Table 136. Pfizer Business Overview
Table 137. Pfizer Bi-Specific MAbS Product
Table 138. Pfizer Revenue in Bi-Specific MAbS Business (2018-2024) & (US$ Million)
Table 139. Pfizer Recent Developments
Table 140. GlaxoSmithKline plc Company Details
Table 141. GlaxoSmithKline plc Business Overview
Table 142. GlaxoSmithKline plc Bi-Specific MAbS Product
Table 143. GlaxoSmithKline plc Revenue in Bi-Specific MAbS Business (2018-2024) & (US$ Million)
Table 144. GlaxoSmithKline plc Recent Developments
Table 145. Roche Company Details
Table 146. Roche Business Overview
Table 147. Roche Bi-Specific MAbS Product
Table 148. Roche Revenue in Bi-Specific MAbS Business (2018-2024) & (US$ Million)
Table 149. Roche Recent Developments
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bi-Specific MAbS Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 2. Global Bi-Specific MAbS Market Share by Type: 2022 VS 2034
Figure 3. Catumaxomab Features
Figure 4. Blinatumomab Features
Figure 5. Duligotumab Features
Figure 6. SAR 156597 Features
Figure 7. Global Bi-Specific MAbS Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 8. Global Bi-Specific MAbS Market Share by Application: 2022 VS 2034
Figure 9. Cancer Case Studies
Figure 10. Autoimmune Diseases Case Studies
Figure 11. Inflammatory Diseases Case Studies
Figure 12. Infectious Diseases Case Studies
Figure 13. Microbial Diseases Case Studies
Figure 14. Others Case Studies
Figure 15. Bi-Specific MAbS Report Years Considered
Figure 16. Global Bi-Specific MAbS Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 17. Global Bi-Specific MAbS Market Size, (US$ Million), 2018 VS 2022 VS 2034
Figure 18. Global Bi-Specific MAbS Market Share by Region: 2022 VS 2034
Figure 19. Global Bi-Specific MAbS Market Share by Players in 2022
Figure 20. Global Top Bi-Specific MAbS Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bi-Specific MAbS as of 2022)
Figure 21. The Top 10 and 5 Players Market Share by Bi-Specific MAbS Revenue in 2022
Figure 22. North America Bi-Specific MAbS Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. North America Bi-Specific MAbS Market Share by Type (2018-2034)
Figure 24. North America Bi-Specific MAbS Market Share by Application (2018-2034)
Figure 25. North America Bi-Specific MAbS Market Share by Country (2018-2034)
Figure 26. United States Bi-Specific MAbS Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. Canada Bi-Specific MAbS Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. Europe Bi-Specific MAbS Market Size YoY (2018-2034) & (US$ Million)
Figure 29. Europe Bi-Specific MAbS Market Share by Type (2018-2034)
Figure 30. Europe Bi-Specific MAbS Market Share by Application (2018-2034)
Figure 31. Europe Bi-Specific MAbS Market Share by Country (2018-2034)
Figure 32. Germany Bi-Specific MAbS Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. France Bi-Specific MAbS Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. U.K. Bi-Specific MAbS Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. Italy Bi-Specific MAbS Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. Russia Bi-Specific MAbS Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. Nordic Countries Bi-Specific MAbS Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. China Bi-Specific MAbS Market Size YoY (2018-2034) & (US$ Million)
Figure 39. China Bi-Specific MAbS Market Share by Type (2018-2034)
Figure 40. China Bi-Specific MAbS Market Share by Application (2018-2034)
Figure 41. Asia Bi-Specific MAbS Market Size YoY (2018-2034) & (US$ Million)
Figure 42. Asia Bi-Specific MAbS Market Share by Type (2018-2034)
Figure 43. Asia Bi-Specific MAbS Market Share by Application (2018-2034)
Figure 44. Asia Bi-Specific MAbS Market Share by Region (2018-2034)
Figure 45. Japan Bi-Specific MAbS Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. South Korea Bi-Specific MAbS Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 47. China Taiwan Bi-Specific MAbS Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 48. Southeast Asia Bi-Specific MAbS Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 49. India Bi-Specific MAbS Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 50. Australia Bi-Specific MAbS Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 51. Middle East, Africa, and Latin America Bi-Specific MAbS Market Size YoY (2018-2034) & (US$ Million)
Figure 52. Middle East, Africa, and Latin America Bi-Specific MAbS Market Share by Type (2018-2034)
Figure 53. Middle East, Africa, and Latin America Bi-Specific MAbS Market Share by Application (2018-2034)
Figure 54. Middle East, Africa, and Latin America Bi-Specific MAbS Market Share by Country (2018-2034)
Figure 55. Brazil Bi-Specific MAbS Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 56. Mexico Bi-Specific MAbS Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 57. Turkey Bi-Specific MAbS Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 58. Saudi Arabia Bi-Specific MAbS Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 59. Israel Bi-Specific MAbS Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 60. GCC Countries Bi-Specific MAbS Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 61. Johnson and Johnson Revenue Growth Rate in Bi-Specific MAbS Business (2018-2024)
Figure 62. Novartis AG Revenue Growth Rate in Bi-Specific MAbS Business (2018-2024)
Figure 63. Hoffmann-La Roche Ltd. Revenue Growth Rate in Bi-Specific MAbS Business (2018-2024)
Figure 64. Chugai Pharmaceutical Revenue Growth Rate in Bi-Specific MAbS Business (2018-2024)
Figure 65. Bayer AG Revenue Growth Rate in Bi-Specific MAbS Business (2018-2024)
Figure 66. Thermo Fisher Scientific Revenue Growth Rate in Bi-Specific MAbS Business (2018-2024)
Figure 67. Bistro-Myers Squibb Revenue Growth Rate in Bi-Specific MAbS Business (2018-2024)
Figure 68. Mylan N.V. Revenue Growth Rate in Bi-Specific MAbS Business (2018-2024)
Figure 69. Daiichi Sankyo Company Revenue Growth Rate in Bi-Specific MAbS Business (2018-2024)
Figure 70. Abbott Revenue Growth Rate in Bi-Specific MAbS Business (2018-2024)
Figure 71. AstraZeneca Revenue Growth Rate in Bi-Specific MAbS Business (2018-2024)
Figure 72. Eli Lilly Revenue Growth Rate in Bi-Specific MAbS Business (2018-2024)
Figure 73. Merck and Co. Revenue Growth Rate in Bi-Specific MAbS Business (2018-2024)
Figure 74. Amgen Revenue Growth Rate in Bi-Specific MAbS Business (2018-2024)
Figure 75. Pfizer Revenue Growth Rate in Bi-Specific MAbS Business (2018-2024)
Figure 76. GlaxoSmithKline plc Revenue Growth Rate in Bi-Specific MAbS Business (2018-2024)
Figure 77. Roche Revenue Growth Rate in Bi-Specific MAbS Business (2018-2024)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries